Arthur He

Stock Analyst at HC Wainwright & Co.

(2.14)

# 2,829

Out of 4,918 analysts

67

Total ratings

45%

Success rate

-5.49%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Arthur He

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AUPH Aurinia Pharmaceuticals	Assumes: Buy	$17	$10.49	+62.06%	1	Jul 30, 2025
	ADAP Adaptimmune Therapeutics	Downgrades: Neutral	n/a	$0.08	-	7	Jul 29, 2025
	NKTR Nektar Therapeutics	Maintains: Buy	$6.5 → $120	$22.96	+422.65%	4	Jun 24, 2025
	SLDB Solid Biosciences	Reiterates: Buy	$20	$6.83	+192.83%	10	Jun 17, 2025
	VERA Vera Therapeutics	Maintains: Buy	$75 → $85	$20.95	+305.73%	2	Jun 2, 2025
	PRME Prime Medicine	Downgrades: Neutral	n/a	$4.04	-	8	May 20, 2025
	ADAG Adagene	Reiterates: Buy	$8	$1.92	+316.67%	10	Apr 3, 2025
	BCAB BioAtla	Reiterates: Neutral	n/a	$0.33	-	8	Mar 31, 2025
	LVTX LAVA Therapeutics	Reiterates: Neutral	$1.5	$1.42	+5.63%	10	Mar 31, 2025
	HOOK HOOKIPA Pharma	Downgrades: Neutral	n/a	$0.89	-	7	Jan 10, 2025

Aurinia Pharmaceuticals

Jul 30, 2025

Assumes: Buy

Price Target: $17

Current: $10.49

Upside: +62.06%

Adaptimmune Therapeutics

Jul 29, 2025

Downgrades: Neutral

Price Target: n/a

Current: $0.08

Upside: -

Nektar Therapeutics

Jun 24, 2025

Maintains: Buy

Price Target: $6.5 → $120

Current: $22.96

Upside: +422.65%

Solid Biosciences

Jun 17, 2025

Reiterates: Buy

Price Target: $20

Current: $6.83

Upside: +192.83%

Vera Therapeutics

Jun 2, 2025

Maintains: Buy

Price Target: $75 → $85

Current: $20.95

Upside: +305.73%

Prime Medicine

May 20, 2025

Downgrades: Neutral

Price Target: n/a

Current: $4.04

Upside: -

Adagene

Apr 3, 2025

Reiterates: Buy

Price Target: $8

Current: $1.92

Upside: +316.67%

BioAtla

Mar 31, 2025

Reiterates: Neutral

Price Target: n/a

Current: $0.33

Upside: -

LAVA Therapeutics

Mar 31, 2025

Reiterates: Neutral

Price Target: $1.5

Current: $1.42

Upside: +5.63%

HOOKIPA Pharma

Jan 10, 2025

Downgrades: Neutral

Price Target: n/a

Current: $0.89

Upside: -